CT Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

CT Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$342K	Sell	6,281 -122	-2%	-$6.69K	0.21%	104
2016 Q4	$374K	Sell	6,403 -180	-3%	-$9.84K	0.24%	97
2016 Q3	$355K	Sell	6,583 -882	-12%	-$56.7K	0.22%	98
2016 Q2	$549K	Sell	7,465 -388	-5%	-$27.4K	0.34%	77
2016 Q1	$502K	Sell	7,853 -400	-5%	-$25.2K	0.28%	86
2015 Q4	$568K	Hold	8,253	–	–	0.33%	78
2015 Q3	$489K	Hold	8,253	–	–	0.31%	82
2015 Q2	$549K	Hold	8,253	–	–	0.31%	81
2015 Q1	$532K	Sell	8,253 -10	-0.1%	-$626	0.29%	83
2014 Q4	$488K	Buy	+8,263	New	+$466K	0.37%	66
2014 Q1	$532K	Buy	+8,253	New	+$439K	0.29%	83

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CT Financial Advisors's BMY Position: Q1 2017 in Review

CT Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q1 2017, selling an estimated $6.69K and leaving 6,281 shares worth $342K. The position accounts for 0.21% of the portfolio, ranked #104.

CT Financial Advisors first reported a position in BMY in Q1 2014 and has held it in 11 quarters since. The position peaked at $568K in Q4 2015. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

CT Financial Advisors held 6,281 shares of Bristol-Myers Squibb worth $342K as of Q1 2017.
CT Financial Advisors sold 122 Bristol-Myers Squibb shares in Q1 2017, an estimated $6.69K.
Bristol-Myers Squibb made up 0.21% of CT Financial Advisors's portfolio in Q1 2017, its #104 holding.
CT Financial Advisors first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's Bristol-Myers Squibb position peaked at $568K in Q4 2015.
1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.